Pharmx Technologies Limited

A$0.07As of Sun 8 Nov 2026, 12:00 UTC
ASX:PHXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 0.12%
Div yield —
ROE (9.31%)
Health Information Services
Beta (5Y) 0.35
PE TTM —
TSR TTM (55.17%)
Mkt cap A$43.46M
ROIC (8.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0668
2.71%
(86.43%)
Hold 3|12|4|10|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
26.74%
20.55%
29.47%
31.59%
Revenue$M
3.354
3.269
3.441
3.364
10.56%
4.53%
6.81%
2.68%
Peers (US$29.85M)
Cap (US$)
PE
25.23M
24.84x
21.05M
—
Capital
TTM
5Y
10Y
Leveragex
2.031
(0.020)
(0.013)
EBIT/Intx
0.544
0.071
0.089
Own earn%
32.99
49.84
52.83
Sh yield%
36.97
30.20
30.34
Owners
Insiders/Inst%
6.46
33.51
Short interest%
2.74
SBC / revenue%
1.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
5–11
$1 testx
—
Incr. ROIC%
1